Evaluation of the Validity of Preemptive Therapy against Cytomegalovirus Disease Based on Antigenemia Assay with a Cutoff of 20 Positive Cells per Two Slides

Overview of attention for article published in PLOS ONE, September 2013

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 21 Dimensions

Readers on

mendeley: 10 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 19,532 followers.

How do we apply this in PCR era? #PLOSONE: Validity of Preemptive Rx against CMV Based on Antigenemia Assay http://t.co/NlfHSdMEew

Reply Repost Favourite